Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-Man Clinical Study to Evaluate the Safety and Efficacy of Renal Artery Radiofrequency Ablation Clamp, Radiofrequency Ablation Generator for the Adjunctive Treatment of Refractory Hypertension and Drug-Intolerant Hypertension

NCT07108829 is registered in ClinicalTrials.gov with Henan Institute of Cardiovascular Epidemiology as lead sponsor.

NCT NCT07108829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07108829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-Man Clinical Study to Evaluate the Safety and Efficacy of Renal Artery Radiofrequency Ablation Clamp, Radiofrequency Ablation Generator for the Adjunctive Treatment of Refractory Hypertension and Drug-Intolerant Hypertension
Lead sponsor
Henan Institute of Cardiovascular Epidemiology
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2025
Completion date
August 31, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory hypertension or drug-intolerant hypertension